Abiopharma

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-25 <b>AccNo:</b> 0001918704-26-024629 <b>Size:</b> 929 KB

General Announcement: Elite UK REIT Secures SGs 1st GBP Sustainability-Linked Shariah-Compliant Murabaha Facility

New Form 424B2 - CITIGROUP INC <b>Filed:</b> 2026-08-25 <b>AccNo:</b> 0001918704-26-024628 <b>Size:</b> 620 KB

General Announcement: Continuing Connected Transaction - Renewal of Land Lease iro Edsa Shangri-La, Manila

Capital Reduction (Impacts shareholder):

New Form CERT - Axos Financial, Inc. <b>Filed:</b> 2026-08-25 <b>AccNo:</b> 0000876882-26-000022 <b>Size:</b> 145 KB

New Form 424B2 - UBS AG <b>Filed:</b> 2026-08-25 <b>AccNo:</b> 0001839882-26-041253 <b>Size:</b> 471 KB

Asset Acquisitions and Disposals: Issuance of 30,067,546 Consideration Units and Payment of Acquisition Fee by Way of Issue of Units

SCHMID Group N.V. reports H1 2026 Financial Results and Updates Full-Year 2026 Guidance

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-25 <b>AccNo:</b> 0001839882-26-041252 <b>Size:</b> 352 KB

📋 WANG YAN (Director) plans to sell 31K shares of WEIBO Corp (at $7.00 each, total $218K) Filed: Aug 25, 2026 | ID: 000305

New Form 425 - Matinas BioPharma Holdings, Inc. <b>Filed:</b> 2026-08-25 <b>AccNo:</b> 0001493152-26-039981 <b>Size:</b> 165 KB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-25 <b>AccNo:</b> 0001839882-26-041251 <b>Size:</b> 202 KB

RXT Investor Losses: Rackspace AI Effort Issues and Corresponding 33% Stock Drop Trigger Securities Class Action for Investors

Change - Announcement of Appointment: Appointment of Independent Director